Casa Aztlan

Casa Aztlan, based in San Bruno, CA, is one of the SAMHSA-registered treatment programs operating in CA. The facility offers specific levels of care: Inpatient, Dual Dx. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Casa Aztlan

The care-level question matters because what a facility offers is what it can realistically treat well. The facility's documented care levels are The facility offers specific levels of care: Inpatient, Dual Dx. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Casa Aztlan's offerings match the clinical need.

Insurance and payment

Casa Aztlan accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult men, Seniors or older adults. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Casa Aztlan offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. Programs that cannot answer all three quickly are programs worth approaching with caution.